| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
AU:RMD
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
|
Jul 20, 2026 | BUY |
Strong Buy
+27.6% avg upside
11 analysts
|
— | +14.6% | · |
|
AU:S32
South32
|
Jan 14, 2026 | HOLD |
Buy
-9.3% avg upside
24 analysts
|
$3.50
26.41% Downside
|
+16.4% | · |
|
RMD
Resmed
|
Dec 12, 2025 | BUY |
Buy
-0.1% avg upside
27 analysts
|
$345.00
49.51% Upside
|
-10.5% | · |
|
AU:RHC
Ramsay Health Care
|
Nov 16, 2025 | HOLD |
Hold
-6.8% avg upside
14 analysts
|
$35.90
20.02% Downside
|
+43.9% | · |
|
AU:CSL
CSL
|
Nov 06, 2025 | BUY |
Strong Buy
+20.7% avg upside
16 analysts
|
$275.00
65.24% Upside
|
-22.8% | · |
|
AU:COH
Cochlear
|
Aug 15, 2025 | BUY |
Buy
+34.5% avg upside
15 analysts
|
$350.00
154.84% Upside
|
-54.0% | · |
|
AU:TLX
Telix Pharmaceuticals
|
Apr 24, 2025 | BUY |
Strong Buy
+48.1% avg upside
14 analysts
|
$36.00
113.80% Upside
|
-44.1% | · |
|
AU:LTR
Liontown Resources Limited
|
Feb 07, 2023 | BUY |
Hold
+10.0% avg upside
15 analysts
|
$1.85
60.93% Upside
|
-37.5% | · |
|
AU:TLC
Lottery Corporation Limited
|
Nov 09, 2022 | BUY |
Buy
+6.6% avg upside
11 analysts
|
$5.40
0.75% Upside
|
+6.5% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.